Pediatric optic pathway gliomas (OPGs) account for 20% of brain tumors [1]. These tumors are characterized by a low-grade growth and in some cases can be associated with a tumor predisposition syndrome. In particular, 15% of patients with neurofibromatosis type 1 (NF1) develop OPGs [2]. Sporadic and NF1-associated OPGs show different outcomes and are characterized by different radiological features [3], nevertheless both forms show activation of the MAPK (mitogen-activated protein kinase) and mTOR pathways.
NF1 Gene Mutation Mediates Neuronal Signaling De-Regulation Triggering Pediatric Optic Glioma Development: Another Small Step towards a Cure of NF1 Disorder? / P. Riva, V. Tritto. - In: EC NEUROLOGY. - 13:9(2021 Aug 12), pp. 11-12.
NF1 Gene Mutation Mediates Neuronal Signaling De-Regulation Triggering Pediatric Optic Glioma Development: Another Small Step towards a Cure of NF1 Disorder?
P. Riva
Primo
Conceptualization
;V. TrittoUltimo
Validation
2021
Abstract
Pediatric optic pathway gliomas (OPGs) account for 20% of brain tumors [1]. These tumors are characterized by a low-grade growth and in some cases can be associated with a tumor predisposition syndrome. In particular, 15% of patients with neurofibromatosis type 1 (NF1) develop OPGs [2]. Sporadic and NF1-associated OPGs show different outcomes and are characterized by different radiological features [3], nevertheless both forms show activation of the MAPK (mitogen-activated protein kinase) and mTOR pathways.
| File | Dimensione | Formato | |
|---|---|---|---|
|
ECNE-13-00940.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
189.79 kB
Formato
Adobe PDF
|
189.79 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
